Sichuan Kelun Pharmaceutical Research Institute Co., Ltd.
Quick facts
Phase 3 pipeline
- KL-140
KL-140 is an investigational drug in phase 3 development by Sichuan Kelun Pharmaceutical, but its specific mechanism of action is not publicly disclosed.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
- Sichuan Kelun Pharmaceutical Research Institute Co., Ltd. portfolio CI brief
- Sichuan Kelun Pharmaceutical Research Institute Co., Ltd. pipeline updates RSS
Frequently asked questions about Sichuan Kelun Pharmaceutical Research Institute Co., Ltd.
What is Sichuan Kelun Pharmaceutical Research Institute Co., Ltd.'s pipeline?
Sichuan Kelun Pharmaceutical Research Institute Co., Ltd. has 1 drugs in Phase 3, 0 in Phase 2, 0 in Phase 1. Late-stage candidates include KL-140.
Related
- Sector hub: All tracked pharma companies